MarketPeel
Insider Trading Intelligence
BA

Bio Ventures Limited Partnership Arkin

KROS
10% OWNER · KEROS THERAPEUTICS, INC. · CIK 0001808348
FILING MIX · LIFETIME57%/43%
BUYS
4
SELLS
3
TOTAL VALUE
$1.92M
COMPANIES
1
ACTIVE SINCE
Apr 2020
HOLDINGS NOW
0
AVG SELL PX
TRADE KIND
SHOWING 7 / 7
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
1 backtested trades · 8 horizons
Forward-return performance of every backtestable P/S trade by Bio Ventures Limited Partnership Arkin, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d1+100.00%+20.53%+2.15%+18.39%+18.39%
14d1+100.00%+30.86%+4.13%+26.73%+26.73%
30d1+100.00%+23.76%+2.15%+21.61%+21.61%
60d1+100.00%+47.65%+10.36%+37.30%+37.30%
90d1+100.00%+32.59%+14.71%+17.87%+17.87%
180d1+100.00%+96.38%+26.89%+69.50%+69.50%
1y1+100.00%+175.72%+52.18%+123.55%+123.55%
2y1+100.00%+182.69%+65.56%+117.14%+117.14%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
KROS · 0 shares · as of Apr 13, 2020
0503,2761,006,5511,509,8272,013,102SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
FLOW · 4 buys / 3 sellsCOVERAGE · 1 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILED
KROS
KEROS THERAPEUTICS, INC.
PURCHASE
167,5371,893,102Apr 13, 2020Apr 13, 2020
KROS
KEROS THERAPEUTICS, INC.
PURCHASE
343,2701,725,565Apr 13, 2020Apr 13, 2020
KROS
KEROS THERAPEUTICS, INC.
SALE
1,382,2950Apr 13, 2020Apr 13, 2020
KROS
KEROS THERAPEUTICS, INC.
PURCHASE
1,382,2951,382,295Apr 13, 2020Apr 13, 2020
KROS
KEROS THERAPEUTICS, INC.
PURCHASE
120,000$16.00$1.92M2,013,102Apr 13, 2020Apr 13, 2020
KROS
KEROS THERAPEUTICS, INC.
SALE
343,2700Apr 13, 2020Apr 13, 2020
KROS
KEROS THERAPEUTICS, INC.
SALE
167,5370Apr 13, 2020Apr 13, 2020
Other insiders · KROS
Loading peer insiders…
About this filer
CIK 0001808348
ROLE
10% Owner
PRIMARY
KROS
COMPANIES
1
ACTIVE SINCE
Apr 2020
MARKETPEEL · /INSIDER/0001808348DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback